semaglutide 5mg vial / Cyanocobalamin Injection Semaglutide 5mg — Selective GLP-1

There is a lack of concluded clinical trials in the literature about the specific use of GLP-1 and its analogs in PA therapeutics

A literature review found that long-term proton pump inhibitor use can cause significant magnesium depletion, leading to secondary electrolyte imbalances including low potassium and calcium (PMID: 39279305)

The decision to initiate GLP-1 therapy should always be based on primary indicationstype 2 diabetes management or weight management in obesitywith lipid improvements considered a valuable secondary benefit

those receiving triple therapy

(2) Without insurance : Use oral Wegovy via NovoCare at $149-$299/month (cheapest option) or injectable at $199-$349/month